Transpl Int. 2011;24(1):21. 18. Ribas A. Overcoming immunologic tolerance to melanoma: targeting CTLA
Transpl Int. 2011;24(1):21. 18. Ribas A. Overcoming immunologic tolerance to melanoma: targeting CTLA4 with tremelimumab (CP675,206). Oncologist. 2008; 13 Suppl 4:105. 19. Ascierto PA, Marincola FM, Ribas A. AntiCTLA4 monoclonal…